Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2003
07/09/2003CN1428348A Clone, expression and biological activity of stingray caudal spine cyclophilin A gene
07/09/2003CN1428347A Clone, expression and biological activity of stingray tumor suppressor gene
07/09/2003CN1114106C Peptide marked with metal chelate and preparing method thereof
07/08/2003US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders
07/08/2003US6590086 Mutants of the Rb and p53 genes and uses thereof
07/08/2003US6590079 Vitazin antibody; treating angiogenesis or restenosis
07/08/2003US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders
07/08/2003US6590072 Method for extractive refolding of scrambled single-chain polypeptides
07/08/2003US6589935 Insulin receptor tyrosine kinase substrate
07/08/2003US6589933 Chemokine binding protein 5(type-2 CBP) encoded by poxviruses and having amino acid sequence homology with the Shope fibroma virus T1 family of proteins against disease syndromes associated with acute or chronic dysregulated inflammatory
07/08/2003US6589764 IL-18 receptor fusion proteins
07/08/2003US6589756 Immunoassays using anti-allotypic monoclonal antibodies
07/08/2003US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening
07/08/2003US6589530 Hepatitis B surface antigen vaccine
07/08/2003US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment
07/08/2003CA2263883C Kuz, a novel family of metalloproteases
07/08/2003CA2133646C Stem cell proliferation factor
07/08/2003CA2080920C Cloning by complementation and related processes
07/08/2003CA2068593C Method for reducing the immunogenicity of antibody variable domains
07/08/2003CA2035384C Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")
07/03/2003WO2003054540A1 Dna encoding a human receptor (hp15a) and uses thereof
07/03/2003WO2003054216A2 Antibodies that immunospecifically bind to trail receptors
07/03/2003WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors
07/03/2003WO2003054188A2 Seminal vesicle tissue-specific promoters and uses thereof
07/03/2003WO2003054185A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease
07/03/2003WO2003054184A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease
07/03/2003WO2003054174A1 Method for large scale production of virus antigen
07/03/2003WO2003054172A2 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
07/03/2003WO2003054156A2 Novel g proein-coupled receptor, gave7
07/03/2003WO2003054155A2 Pichia pastoris formate dehydrogenase and uses therefor
07/03/2003WO2003054140A2 Phosphate limited inducible promoter and a bacillus expression system
07/03/2003WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003WO2003054014A2 Apolipoprotein biopolymer markers predictive of alzheimers disease
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003053995A2 Soybean phosphopeptide calcium and method for producing thereof
07/03/2003WO2003053921A2 Mutant proteinase inhibitors and uses thereof
07/03/2003WO2003053158A2 Malleable protein matrix and uses thereof
07/03/2003WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
07/03/2003WO2003025016A3 Trk polypeptide purification method
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures
07/03/2003WO2002090495A8 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
07/03/2003WO2002070672A3 Plant cell having animal-type sugar chain adding function
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002059604A3 Diagnosis and treatment of multiple sclerosis
07/03/2003WO2002057468A3 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
07/03/2003WO2002050285A3 Histone deacetylase-related gene and protein
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002036761A3 Compositions and methods for the diagnosis of cancer
07/03/2003WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/03/2003WO2002024733A3 Human polynucleotides and polypeptides encoded thereby
07/03/2003WO2001083750A9 Dendritic cell co-stimulator molecules
07/03/2003US20030126648 Plasmid coding virginiae butanolide; virginiamycin; BAR receptor binding proteins
07/03/2003US20030126624 Chimeric DNA-binding proteins
07/03/2003US20030125538 Amino acid transporters and uses
07/03/2003US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome
07/03/2003US20030125535 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030125534 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry
07/03/2003US20030125524 Fusion proteins; interleukins; colony stimulating factors; cellular proliferation/differentiation; culturing bone marrow or peripheral blood cells; natural killer cells
07/03/2003US20030125523 Novel neuropilin/growth factor complexes and uses thereof
07/03/2003US20030125522 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
07/03/2003US20030125521 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125515 Endcapped genetically engineered human immunodeficiency viral polypeptides; viricides
07/03/2003US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems
07/03/2003US20030125246 Respiratory system related polynucleotides and the polypeptides encoded by these polynucleotides known as respiratory system antigens useful for detecting cancer or cancer metastases of respiratory system tissues
07/03/2003US20030125232 Stabilized proteins with engineered disulfide bonds
07/03/2003US20030124721 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
07/03/2003US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents
07/03/2003US20030124697 Enzymatic protein for use in preparation of pantothenic acid and pantethine; vitamins
07/03/2003US20030124696 Mixing salt of tris(m-sulfonatophenyl)phosphine with oxidoreductases and reducing with hydrogen
07/03/2003US20030124695 Genes encoding baeyer-villiger monooxygenases
07/03/2003US20030124678 Interleukin-2 mutants with reduced toxicity
07/03/2003US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists
07/03/2003US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA
07/03/2003US20030124674 Batch fermentation of polypeptides; cosmetics; foods; medicines
07/03/2003US20030124673 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
07/03/2003US20030124667 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124664 Aminopeptidase
07/03/2003US20030124663 Membrane proteins; antiproliferative agents; antitumor agents; antisense agents; neovascularization
07/03/2003US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124659 Multiplexing method
07/03/2003US20030124655 Receptor protein specifically recognizing bacterial dna
07/03/2003US20030124653 Preparing preferential enzymatic polypeptide; lysosomal hydrolases; phosphotransferases; lysosomal storage disease; translation inhibit; enzyme replacement therapy
07/03/2003US20030124650 Isolating streptomyces serine proteases using immunoaffinity chromatography; oligopeptides
07/03/2003US20030124649 Membrane associated proteins
07/03/2003US20030124648 Vector/plasmid for efficient and accurate transfer of preferential gene to rodent cells; glutamine synthetases
07/03/2003US20030124645 Practical in vitro sialylation of recombinant glycoproteins
07/03/2003US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents
07/03/2003US20030124614 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
07/03/2003US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor
07/03/2003US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
07/03/2003US20030124533 HIP1 cancer markers
07/03/2003US20030124531 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2)
07/03/2003US20030124520 Methods for identifying agents that cause a lethal phenotype, and agents thereof
07/03/2003US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof
07/03/2003US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix
07/03/2003US20030124138 Endogenous activating ligand which is a potentially important neuroregulator.
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
1 ... 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 ... 1125